Catherine Hye-Won Han

7PUBLICATIONS

30CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Cultural theoryHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 13, 2026

Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer.

|Apr 30, 2026

Evaluating Oxaliplatin Exposure in Adults with Advanced Colorectal Cancer: Development and Validation of Methods with Enhanced Bioanalytical Specificity and Clinical Applicability.

|Mar 27, 2026

Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With <i>BRAF</i> V600-Mutant Solid Tumors.

Maria Vieito, Elisa Fontana, Catherine H Han

|Mar 26, 2025

Contemporary Patterns of Care for Low-Grade Glioma in Australia and New Zealand.

Meghana Maddula, Nicholas McNamee, Hui K Gan

|Dec 27, 2023

Exploring the Important Determinants Shaping Treatment Preferences: Qualitative Insights into Breast Cancer Patient Experiences and Perspectives in New Zealand.

Hui Yee Yeo, Jacqueline Hui Yi Wong, Suz Jack Chan

|Nov 06, 2023

Understanding Patient Preferences Regarding the Important Determinants of Breast Cancer Treatment: A Narrative Scoping Review.

Hui Yee Yeo, Ai Ch'i Liew, Suz Jack Chan

Pageof 2

Frequent Collaborators

Hui Yee Yeo

Mudassir Anwar

Carlo A Marra

Irene Moreno

Maria Vieito

Elisa Fontana

Eduardo Castañón Álvarez

2 joint publications

David J Pinato

2 joint publications

Oliver Bechter

2 joint publications

Rikke L Eefsen

Frequent Collaborators

Hui Yee Yeo

Mudassir Anwar

Carlo A Marra

Irene Moreno